ロード中...
IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells
Estrogen receptor-, progesterone receptor- and HER2-negative breast cancers, also known as triple-negative breast cancers (TNBCs), have poor prognoses and are refractory to current therapeutic agents, including epidermal growth factor receptor (EGFR) inhibitors. Resistance to anti-EGFR therapeutic a...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5288192/ https://ncbi.nlm.nih.gov/pubmed/27462789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10804 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|